Mark H H Kramer

10PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsWastewater treatment processesMetabolic medicineMolecular targetsNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 02, 2026
Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Luxcia Kugathasan, Michael A Tsoukas, Massimo Nardone

|Jan 27, 2026
Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial.

Massimo Nardone, Erik Moedt, Hiddo J L Heerspink

|Oct 23, 2025
Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.

Pedro Carrera-Bastos, Marcel H A Muskiet, Fernando Mata-Ordoñez

|Jan 10, 2025
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.

Ellen M Apperloo, Hiddo J L Heerspink, Annemarie B van der Aart

|Sep 28, 2021
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.

Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits

|Dec 15, 2020
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.

Rosalie A Scholtes, Marcel H A Muskiet, Michiel J B van Baar

Pageof 2

Frequent Collaborators

4 joint publications

Mark M Smits

4 joint publications

D Margriet Ouwens

4 joint publications

Jens J Holst

4 joint publications

Jaap A Joles